ALEMBIC PHARMACEUTICALS
|
ALEMBIC PHARMACEUTICALS Last 5 Year Income Statement History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| INCOME : | |||||
| Gross Sales | ₹14,252 Cr | ₹13,413 Cr | ₹6,229 Cr | ₹5,653 Cr | ₹5,306 Cr |
| Sales | ₹14,120 Cr | ₹13,280 Cr | ₹6,112 Cr | ₹5,500 Cr | ₹5,232 Cr |
| Job Work/ Contract Receipts | - | - | - | - | - |
| Processing Charges / Service Income | ₹9.98 Cr | ₹17 Cr | ₹12 Cr | ₹25 Cr | ₹15 Cr |
| Revenue from property development | - | - | - | - | - |
| Other Operational Income | ₹122 Cr | ₹116 Cr | ₹104 Cr | ₹128 Cr | ₹59 Cr |
| Less: Excise Duty | - | - | - | - | - |
| Net Sales | ₹7,345 Cr | ₹6,672 Cr | ₹6,229 Cr | ₹5,653 Cr | ₹5,306 Cr |
| EXPENDITURE : | |||||
| Increase/Decrease in Stock | ₹-272 Cr | ₹-290 Cr | ₹-143 Cr | ₹79 Cr | ₹-43 Cr |
| Raw Material Consumed | ₹2,256 Cr | ₹2,083 Cr | ₹1,858 Cr | ₹1,630 Cr | ₹1,490 Cr |
| Opening Raw Materials | ₹628 Cr | ₹386 Cr | ₹390 Cr | ₹456 Cr | ₹443 Cr |
| Purchases Raw Materials | ₹1,723 Cr | ₹1,915 Cr | ₹1,399 Cr | ₹1,184 Cr | ₹1,203 Cr |
| Closing Raw Materials | ₹604 Cr | ₹628 Cr | ₹386 Cr | ₹390 Cr | ₹517 Cr |
| Other Direct Purchases / Brought in cost | ₹509 Cr | ₹411 Cr | ₹455 Cr | ₹380 Cr | ₹361 Cr |
| Other raw material cost | - | - | - | - | - |
| Power & Fuel Cost | ₹178 Cr | ₹180 Cr | ₹173 Cr | ₹152 Cr | ₹121 Cr |
| Electricity & Power | ₹178 Cr | ₹180 Cr | ₹173 Cr | ₹152 Cr | ₹121 Cr |
| Oil, Fuel & Natural gas | - | - | - | - | - |
| Coals etc | - | - | - | - | - |
| Other power & fuel | - | - | - | - | - |
| Employee Cost | ₹1,732 Cr | ₹1,562 Cr | ₹1,446 Cr | ₹1,169 Cr | ₹1,133 Cr |
| Salaries, Wages & Bonus | ₹1,578 Cr | ₹1,426 Cr | ₹1,330 Cr | ₹1,072 Cr | ₹1,045 Cr |
| Contributions to EPF & Pension Funds | ₹101 Cr | ₹92 Cr | ₹81 Cr | ₹68 Cr | ₹60 Cr |
| Workmen and Staff Welfare Expenses | ₹53 Cr | ₹44 Cr | ₹35 Cr | ₹29 Cr | ₹28 Cr |
| Other Employees Cost | - | - | - | - | - |
| Other Manufacturing Expenses | ₹508 Cr | ₹441 Cr | ₹388 Cr | ₹409 Cr | ₹379 Cr |
| Sub-contracted / Out sourced services | - | - | - | - | - |
| Processing Charges | ₹63 Cr | ₹64 Cr | ₹68 Cr | ₹51 Cr | ₹19 Cr |
| Repairs and Maintenance | ₹94 Cr | ₹87 Cr | ₹81 Cr | ₹66 Cr | ₹52 Cr |
| Packing Material Consumed | - | - | - | - | - |
| Other Mfg Exp | ₹350 Cr | ₹289 Cr | ₹238 Cr | ₹293 Cr | ₹308 Cr |
| General and Administration Expenses | ₹682 Cr | ₹576 Cr | ₹526 Cr | ₹493 Cr | ₹414 Cr |
| Rent , Rates & Taxes | ₹24 Cr | ₹18 Cr | ₹18 Cr | ₹17 Cr | ₹15 Cr |
| Insurance | ₹21 Cr | ₹26 Cr | ₹21 Cr | ₹19 Cr | ₹18 Cr |
| Printing and stationery | - | - | - | - | - |
| Professional and legal fees | ₹280 Cr | ₹208 Cr | ₹199 Cr | ₹210 Cr | ₹191 Cr |
| Traveling and conveyance | ₹244 Cr | ₹223 Cr | ₹202 Cr | ₹171 Cr | ₹126 Cr |
| Other Administration | ₹113 Cr | ₹101 Cr | ₹86 Cr | ₹75 Cr | ₹64 Cr |
| Selling and Distribution Expenses | ₹1,083 Cr | ₹1,065 Cr | ₹997 Cr | ₹952 Cr | ₹890 Cr |
| Advertisement & Sales Promotion | ₹761 Cr | ₹733 Cr | ₹733 Cr | ₹681 Cr | ₹634 Cr |
| Sales Commissions & Incentives | - | - | - | - | - |
| Freight and Forwarding | ₹322 Cr | ₹331 Cr | ₹264 Cr | ₹271 Cr | ₹256 Cr |
| Handling and Clearing Charges | - | - | - | - | - |
| Other Selling Expenses | - | - | - | - | - |
| Miscellaneous Expenses | ₹60 Cr | ₹52 Cr | ₹51 Cr | ₹61 Cr | ₹48 Cr |
| Bad debts /advances written off | ₹0.99 Cr | ₹5.31 Cr | ₹2.86 Cr | ₹6.35 Cr | ₹5.24 Cr |
| Provision for doubtful debts | ₹0.93 Cr | ₹3.46 Cr | ₹5.36 Cr | - | ₹7.30 Cr |
| Losson disposal of fixed assets(net) | ₹2.17 Cr | - | - | ₹4.70 Cr | - |
| Losson foreign exchange fluctuations | - | ₹0.09 Cr | - | ₹0.09 Cr | - |
| Losson sale of non-trade current investments | - | - | - | - | - |
| Other Miscellaneous Expenses | ₹56 Cr | ₹43 Cr | ₹43 Cr | ₹50 Cr | ₹35 Cr |
| Less: Expenses Capitalised | - | - | - | - | - |
| Total Expenditure | ₹6,227 Cr | ₹5,669 Cr | ₹5,296 Cr | ₹4,945 Cr | ₹4,432 Cr |
| Operating Profit (Excl OI) | ₹1,118 Cr | ₹1,003 Cr | ₹933 Cr | ₹708 Cr | ₹874 Cr |
| Other Income | ₹55 Cr | ₹48 Cr | ₹29 Cr | ₹3.04 Cr | ₹50 Cr |
| Interest Received | ₹0.86 Cr | ₹5.96 Cr | ₹2.09 Cr | ₹0.33 Cr | ₹1.73 Cr |
| Dividend Received | - | - | ₹0.01 Cr | - | - |
| Profit on sale of Fixed Assets | - | ₹3.26 Cr | ₹1.70 Cr | - | ₹0.54 Cr |
| Profits on sale of Investments | ₹0.39 Cr | ₹1.07 Cr | ₹1.63 Cr | ₹0.61 Cr | ₹2.87 Cr |
| Provision Written Back | - | - | - | - | - |
| Foreign Exchange Gains | ₹50 Cr | ₹23 Cr | ₹18 Cr | - | ₹44 Cr |
| Others | ₹3.46 Cr | ₹14 Cr | ₹5.92 Cr | ₹2.10 Cr | ₹1.04 Cr |
| Operating Profit | ₹1,173 Cr | ₹1,051 Cr | ₹962 Cr | ₹711 Cr | ₹925 Cr |
| Interest | ₹94 Cr | ₹79 Cr | ₹56 Cr | ₹50 Cr | ₹18 Cr |
| InterestonDebenture / Bonds | - | - | - | - | - |
| Interest on Term Loan | - | - | - | - | - |
| Intereston Fixed deposits | - | - | - | - | - |
| Bank Charges etc | - | - | - | - | - |
| Other Interest | ₹94 Cr | ₹79 Cr | ₹56 Cr | ₹50 Cr | ₹18 Cr |
| PBDT | ₹1,079 Cr | ₹972 Cr | ₹905 Cr | ₹661 Cr | ₹907 Cr |
| Depreciation | ₹319 Cr | ₹279 Cr | ₹273 Cr | ₹275 Cr | ₹287 Cr |
| Profit Before Taxation & Exceptional Items | ₹761 Cr | ₹693 Cr | ₹633 Cr | ₹386 Cr | ₹620 Cr |
| Exceptional Income / Expenses | ₹-67 Cr | ₹13 Cr | - | - | - |
| Profit Before Tax | ₹694 Cr | ₹707 Cr | ₹632 Cr | ₹355 Cr | ₹625 Cr |
| Provision for Tax | ₹23 Cr | ₹125 Cr | ₹16 Cr | ₹13 Cr | ₹104 Cr |
| Current Income Tax | ₹128 Cr | ₹123 Cr | ₹66 Cr | ₹4.20 Cr | ₹129 Cr |
| Deferred Tax | ₹-104 Cr | ₹2.99 Cr | ₹-46 Cr | ₹9.20 Cr | ₹-23 Cr |
| Other taxes | - | ₹-0.51 Cr | ₹-3.74 Cr | ₹-0.80 Cr | ₹-1.25 Cr |
| Profit After Tax | ₹671 Cr | ₹582 Cr | ₹616 Cr | ₹342 Cr | ₹521 Cr |
| Extra items | - | - | - | - | - |
| Minority Interest | ₹3.94 Cr | ₹1.41 Cr | - | - | - |
| Share of Associate | - | - | - | - | - |
| Other Consolidated Items | - | - | - | - | - |
| Consolidated Net Profit | ₹675 Cr | ₹583 Cr | ₹616 Cr | ₹342 Cr | ₹521 Cr |
| Adjustments to PAT | - | - | - | - | - |
| Profit Balance B/F | ₹4,394 Cr | ₹4,027 Cr | ₹3,568 Cr | ₹2,554 Cr | ₹2,385 Cr |
| Appropriations | ₹5,069 Cr | ₹4,610 Cr | ₹4,184 Cr | ₹2,896 Cr | ₹2,906 Cr |
| General Reserves | - | - | - | ₹-869 Cr | - |
| Proposed Equity Dividend | - | - | - | - | - |
| Corporate dividend tax | - | - | - | - | - |
| Other Appropriation | ₹215 Cr | ₹216 Cr | ₹157 Cr | ₹197 Cr | ₹351 Cr |
| Equity Dividend % | ₹600.00 | ₹550.00 | ₹550.00 | ₹400.00 | ₹500.00 |
| Earnings Per Share | ₹34.33 | ₹29.68 | ₹31.33 | ₹17.40 | ₹26.50 |
| Adjusted EPS | ₹34.33 | ₹29.68 | ₹31.33 | ₹17.40 | ₹26.50 |
Compare Income Statement of peers of ALEMBIC PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALEMBIC PHARMACEUTICALS | ₹16,540.9 Cr | 0.5% | 12.6% | -13.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,870.0 Cr | 0.8% | 8.3% | 17.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,316.0 Cr | 7.1% | 9% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹169,316.0 Cr | 2% | 12.1% | 49.6% | Stock Analytics | |
| CIPLA | ₹115,477.0 Cr | -0.7% | 4.1% | -3.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,156.0 Cr | -1.7% | -4.2% | -3.1% | Stock Analytics | |
ALEMBIC PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALEMBIC PHARMACEUTICALS | 0.5% |
12.6% |
-13.8% |
| SENSEX | 0.6% |
1.2% |
-7.8% |
You may also like the below Video Courses